Differential Diagnosis Athlete's Heart From Cardiomyopathy

Athlete's Heart Clinical Trial

Official title:

Differential Diagnosis Athlete's Heart From Hypertrophic Cardiomyopathy With T1 Mapping

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04970758
• Other study ID #: M2019298
• Status: Completed
• Start date: January 16, 2019
• Est. completion date: December 12, 2020

Study information

• Verified date: June 2021
• Source: Peking University Third Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Assess the effects of strength sport to heart structure and function by T1 mapping with cardiac resonance imaging.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: December 12, 2020
• Est. primary completion date: November 1, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 35 Years

Eligibility

Inclusion Criteria:

• Same exercise

Exclusion Criteria:

• Intolerance test

Related Conditions & MeSH terms

• Athlete's Heart
• Cardiomyopathies

Locations

Country	Name	City	State
China	Peking University Third Hospital	Beijing	Beijing

Sponsors (1)

Lead Sponsor	Collaborator
Peking University Third Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	T1 value in ms (Unit)	indicator of the degree of myocardial fibrosis	one year